1. Technical Field
The present disclosure relates to medical apparatus including a valve assembly having a dissolvable valve member and, more particularly, to a relief valve assembly having a dissolvable valve member for use with a urinary catheter.
2. Background of Related Art
Urinary catheters for draining fluid from a patient's bladder are well known in the art. Typically, urinary catheters include a flexible body which is dimensioned to be inserted through the urethra into the bladder. The distal end of the catheter includes an expandable bulb or balloon which can be expanded within the bladder, via a gas inlet valve and conduit, to retain the distal end of the catheter within the bladder. The flexible body further defines a drain lumen which allows fluid to drain from the bladder into a urine collection bag. The urinary catheter also includes a sampling port and an irrigation lumen which allows an irrigation fluid to be injected through the catheter into the bladder to irrigate the bladder. In addition to facilitating withdrawal of urine from the catheter for testing, the sampling port can also be used to inject an anti-microbial solution into the catheter to reduce the risk of infection to the patient.
When an irrigation fluid and/or an anti-microbial solution is injected into a catheter, medical personnel must clamp the catheter downstream of the injection site for a specified period of time to prevent the irrigation fluid and/or anti-microbial solution from immediately draining from the bladder and/or catheter. If the medical personnel fail to remove the clamp, fluid will back up in the bladder and result in discomfort and potential serious harm to the patient.
Accordingly, a continuing need exists in the medical arts for a device usable with a catheter which can retain an irrigation solution and/or anti-microbial solution within a catheter for a specified period of time and, thereafter, permit drainage of the catheter without intervention by medical personnel.
A valve assembly is provided which includes a housing having an inlet end and an outlet end and defining a fluid channel and a central chamber. A dissolvable valve member is positioned to obstruct flow through the channel within the chamber. The dissolvable valve member is formed of a material which is dissolvable at a predetermined rate upon contact with a preselected fluid. The preselected fluid is selected from the group consisting of blood, urine, saline and antimicrobial solutions. The dissolvable valve member can be formed from a fluid soluble glass or a starch based material. Alternatively, the use of other dissolvable materials is envisioned. The housing can include an inlet housing portion and an outlet housing portion which are configured to be secured together to define the central chamber. The inlet end of the housing is adapted to releaseably engage a drain lumen of a medical device, e.g., urinary catheter. The outlet end of the housing is adapted to releasably engage a fluid conduit of a urine collection system. In one embodiment, the housing has at least one vent configured to vent air from within the valve assembly. The at least one vent can include an inlet vent and an outlet vent.
In one embodiment, the dissolvable valve member is formed from a thin dissolvable material. In another embodiment, the dissolvable valve member includes a substantially cylindrical body having an inlet side and an outlet side. At least one of the inlet side and the outlet side can define a spherical concavity. Alternatively, the cylindrical body can have substantially rectangular cross-section. In one embodiment, the cylindrical body defines a stepped cross-section, wherein a central portion of the body has a smaller width than an outer portion of the body. The body can define one or more throughbores.
A urinary catheter assembly is also provided which includes a catheter having a body defining a central drain lumen for positioning within a bladder of a patient having an outlet end defining a drain lumen outlet. A valve assembly includes a housing adapted to releasably engage the outlet end of the body of the catheter. The housing defines a fluid channel and a chamber. The valve assembly further includes a dissolvable valve member positioned to obstruct flow through the channel. The dissolvable valve member can be formed of a material which is dissolvable at a predetermined rate upon contact with a preselected fluid. The preselected fluid can be selected from the group consisting of blood, urine, saline and antimicrobial solutions. The dissolvable valve member can be formed from a fluid soluble glass or a starch based material. The housing can have at least one vent configured to vent air from within the valve assembly. Alternatively, the dissolvable valve member can be formed from a thin dissolvable material.
Various embodiments of the presently disclosed valve assembly including a dissolvable valve member are disclosed herein with reference to the drawings, wherein:
Embodiments of the presently disclosed valve assembly including a dissolvable valve member will now be described in detail with reference to the drawings wherein like reference numerals designate identical or corresponding elements in each of the several views.
Outlet housing portion 14 defines a fluid channel 18a which is in fluid communication with fluid channel 18 of inlet housing portion 12. An inlet end 30 of outlet housing portion 14 has an inner stepped portion 32 which is dimensioned to receive annular extension 28 of inlet housing portion 12. Inner stepped portion 32 has a width which is greater than the width of annular extension 28 such that inner stepped portion 32 defines a shoulder 32a. Shoulder 32a and annular extension 28 together define cylindrical chamber 34. Chamber 34 is dimensioned to receive dissolvable valve member 16 as will be discussed in further detail below. Outlet end 22 of housing portion 12 is secured to inlet end 30 of outlet housing portion 14 such as by sonic welding, adhesives, screw threads, or the like, such that dissolvable valve member 16 is retained in chamber 34.
Inlet and outlet housing portions 12 and 14 can be formed from a clear or transparent material, e.g., transparent polymeric materials including polycarbonates. One such material which is commercially available is LEXAN®. A transparent material allows medical personnel to visually confirm that the valve assembly 10 is functioning properly, i.e., that the valve member 16 has dissolved in the specified period of time and that fluid is flowing through the valve assembly 10. It is envisioned that the valve member can include a contrasting color to improve visualization of the valve member.
Each of inlet and outlet housing portions 12 and 14 also includes a vent. More specifically, an upper vent 38 is supported on inlet housing portion 12 and a lower vent 40 is supported on housing portion 14. Vents 38 and 40 allow air from within catheter 50 and valve assembly 10 to be removed from fluid channels 18 and 18a. An outlet end 42 of housing portion 14 includes a thin walled extension 42a (
Referring now to
Catheter assembly 50 includes a body defining a central drain lumen 72 (
When inlet end 20 of inlet housing portion 12 of valve assembly 10 is releasably coupled with catheter assembly 50 and a distal end of catheter assembly 50 is inserted into a patient's bladder, an irrigation solution can be injected into the bladder by injecting the solution, e.g., saline, through the irrigation lumen 78 into the bladder. An anti-microbial solution, e.g., ethylene diamine tetracetic acid (“EDTA”), can also be injected through supply port 76 into central drain lumen 72 of catheter assembly 50 to flush or lock the catheter. When an irrigation fluid and/or anti-microbial solution is injected into catheter assembly 50, the fluid will flow into central drain lumen 72 and enter channel 18 of inlet housing portion 12 of valve assembly 10. The dissolvable valve member 16 of valve assembly 10 is positioned between channel 18 of inlet housing portion 12 and channel 18a of outlet housing portion 14 to prevent or obstruct fluid from exiting drain lumen 72 until a predetermined period of time has elapsed. The dissolvable valve member 16 of valve assembly 10 allows medical personnel to lock and flush catheter assembly 50 without the need of a mechanical clamping device to ensure that drainage is reestablished without medical personnel intervention.
As discussed above, valve member 16 can be constructed from fluid soluble glass or, alternatively, from starch based materials, which can be designed to dissolve over time after exposure to blood, urine, saline or antimicrobial solutions such as EDTA. The soluble glass used may comprise phosphorus pent oxide as the principle glass forms together with any one or more glass-modifying non-toxic materials such as sodium oxide, potassium oxide, magnesium oxide and calcium oxide. Alternatively, other dissolvable materials may be used to form the valve member. Further, the dissolvable material, e.g., glass can be impregnated with a drug or anti-microbial which is released into the catheter or other medical device as the valve member dissolves. The materials noted above can be engineered to dissolve over specific time periods such as seconds, minutes and hours. Combinations of fluid temperature, valve surface area, geometry and material dissolution rate for both soluble glass and starch based material valve members allow for an infinite number of time ranges to be established in which the valve member would dissolve and fluid flow from the catheter would be reestablished.
It is envisioned that a variety of valve member configurations can be used to achieve the advantages described. Only a few representative embodiments have been described herein. For example, the valve member need not be cylindrical but rather may assume a variety of different configurations, e.g., square, triangular, rectangular, etc.
In use, valve assembly 400 functions in a manner similar to valve assembly 10 as described above. More specifically, when a fluid, e.g., urine, blood, EDTA, etc., flows through inlet conduit 420 into valve chamber 430, the fluid engages valve member 416 causing valve member 416 to dissolve at a specified rate. When valve member 416 dissolves, fluid is able to flow through valve member 416 through outlet conduit 422.
It will be understood that various modifications may be made to the embodiments disclosed herein. For example, the valve assembly and/or valve member may assume a variety of configurations not shown herein, e.g., rectangular, square, oval, etc. Further, the valve assembly can be used in association with medical devices other than urinary catheters, including, for example, blood collection devices, IV administration sets, and abdominal drainage tubes. It is also envisioned that one or more dissolvable valve members can be used together. For example, three “five minute” dissolvable valve members may be used together to allow medical personnel to assess more easily the time remaining to re-establish flow. Therefore, the above description should not be construed as limiting, but merely as exemplifications of embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.
This application is a continuation application of and claims the benefit of priority under 35 U.S.C. §120 to co-pending U.S. patent application Ser. No. 12/485,205, filed Jun. 16, 2009, entitled Valve Assembly Including a Dissolvable Valve Member, which claims priority under 35 U.S.C. §119(e) to U.S. provisional application Ser. No. 61/076,850, filed Jun. 30, 2008. Each of the preceding applications is herein incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3511254 | Dyer et al. | May 1970 | A |
3586018 | Bogardh et al. | Jun 1971 | A |
3848603 | Throner | Nov 1974 | A |
4601880 | Wong et al. | Jul 1986 | A |
4693712 | Bates | Sep 1987 | A |
5049139 | Gilchrist | Sep 1991 | A |
5122118 | Haber et al. | Jun 1992 | A |
5201724 | Hukins et al. | Apr 1993 | A |
5470585 | Gilchrist | Nov 1995 | A |
5509889 | Kalb et al. | Apr 1996 | A |
5558629 | Baerveldt et al. | Sep 1996 | A |
5800339 | Salama | Sep 1998 | A |
5860916 | Pylant | Jan 1999 | A |
5894608 | Birbara | Apr 1999 | A |
6050934 | Mikhail et al. | Apr 2000 | A |
6145593 | Hennig | Nov 2000 | A |
6183437 | Walker | Feb 2001 | B1 |
6245228 | Kelada | Jun 2001 | B1 |
6551838 | Santini, Jr. et al. | Apr 2003 | B2 |
6793651 | Bennett et al. | Sep 2004 | B1 |
7226441 | Kulessa | Jun 2007 | B2 |
7410481 | Mitts et al. | Aug 2008 | B1 |
8518019 | Green | Aug 2013 | B2 |
20010037097 | Cheng et al. | Nov 2001 | A1 |
20020143318 | Flinchbaugh | Oct 2002 | A1 |
20030171768 | McGhan | Sep 2003 | A1 |
20030175853 | Clarke et al. | Sep 2003 | A1 |
20030208183 | Whalen et al. | Nov 2003 | A1 |
20050137570 | Jones et al. | Jun 2005 | A1 |
20050148999 | Beaufore et al. | Jul 2005 | A1 |
20050256447 | Richardson et al. | Nov 2005 | A1 |
20050271698 | Bucay-Couto et al. | Dec 2005 | A1 |
20060047247 | Anders | Mar 2006 | A1 |
20060093528 | Banjeree et al. | May 2006 | A1 |
20060142736 | Hissink et al. | Jun 2006 | A1 |
20060212024 | Blake et al. | Sep 2006 | A1 |
20070034817 | Guest et al. | Feb 2007 | A1 |
20070270734 | Crisp | Nov 2007 | A1 |
20080051763 | Frojd | Feb 2008 | A1 |
20080069729 | McNeely | Mar 2008 | A1 |
20080071250 | Crisp | Mar 2008 | A1 |
20080188770 | Hannon | Aug 2008 | A1 |
20090264840 | Virginio | Oct 2009 | A1 |
20090326483 | Green | Dec 2009 | A1 |
Number | Date | Country |
---|---|---|
0258057 | Mar 1988 | EP |
0399652 | Nov 1990 | EP |
1534219 | Nov 1978 | GB |
62-90642 | Jun 1987 | JP |
63-129008 | Jun 1988 | JP |
3-73122 | Jul 1991 | JP |
06-63132 | Mar 1994 | JP |
6-66661 | Sep 1994 | JP |
2001-046493 | Feb 2001 | JP |
2001-116863 | Apr 2001 | JP |
8901793 | Mar 1989 | WO |
8905127 | Jun 1989 | WO |
9966976 | Dec 1999 | WO |
0047143 | Aug 2000 | WO |
2004041122 | May 2004 | WO |
2004062532 | Jul 2004 | WO |
2006020929 | Feb 2006 | WO |
2006063593 | Jun 2006 | WO |
2007018963 | Feb 2007 | WO |
2007087061 | Aug 2007 | WO |
Entry |
---|
European Search Report dated Mar. 25, 2014 for counterpart European Application No. 14152055.1. |
Translated Office Action dated Jul. 18, 2013 issued by the Japanese Patent Office in counterpart Japanese Application No. 2009-150516. |
European Search Report dated Oct. 5, 2009 for copending European Application No. EP 09 16 3472. |
Translated Examination Report dated Mar. 6, 2013 issued by the Mexican Patent Office in counterpart Mexican Application No. MX/a/2009/006968. |
Number | Date | Country | |
---|---|---|---|
20130310811 A1 | Nov 2013 | US |
Number | Date | Country | |
---|---|---|---|
61076850 | Jun 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12485205 | Jun 2009 | US |
Child | 13932349 | US |